Home › Kidney Diseases › NCT04182607
Donor Outcomes Following Hand-Assisted and Robotic Living Donor Nephrectomy: a Retrospective Review
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * ≥ 18 years of age * Kidney donors and recipients who underwent a hand-assisted or robotic kidney transplant Exclusion Criteria: * Patients that do not meet the Study Inclusion Criteria laid out above
About the study
1.1. Background: Renal transplantation is the treatment of choice for eligible patients with end-stage renal disease. It provides better outcomes in terms of life expectancy and quality of life than dialysis (Liu, Narins, Maley, Frank, \& Lallas, 2012). Kidney transplants from living donors also have additional benefits in terms of graft function and survival compared to transplants from cadaver donors (Galvani et al., 2012). Living donor transplants provide an opportunity to have good quality grafts and to perform the procedure when the recipient is in an optimal clinical status (Creta et al., 2019).
Laparoscopic donor nephrectomy was first introduced in 1995 and is currently accepted as the gold standard for kidney procurement from living donors. The first worldwide robotic assisted laparoscopic donor nephrectomy was performed in 2000 by Horgan et al. (Horgan et al., 2007).
The main obstacle to living donation is the exposure of a healthy subject to the risks of a major surgical intervention. Therefore, efforts have been made to reduce complications and postoperative pain, achieve faster recovery, and minimize the surgical incisions.
Minimally invasive procedures like hand-assisted and robotic approaches greatly enhance living donation rates, and in 2001 the number of living donors exceeded the number of cadaver donors (Horgan et al., 2007).
1.2. Aim(s)/Objective(s): The objective of this study is to compare intra- and postoperative patient outcomes of kidney donors following hand-assisted and robotic kidney transplants at a single center.
1.3. Rationale for the study: More research is needed regarding the differences between minimally invasive approaches to kidney transplantation.
What is being tested
- kidney transplant (procedure)
Sponsor: Methodist Health System · Participants: 240 · Started: Nov 6, 2019
Contact the study team
- Crystee Cooper, DHEd · Phone: 214-947-1280
- Zaid Haddadin, MS · Phone: 214-947-1280
Official record on ClinicalTrials.gov — NCT04182607
Locations in the U.S.
| Texas | The Liver Institute at Methodist Dallas Medical Center, Dallas |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.